Glucose metabolism and insulin resistance in sepsis

被引:95
作者
Van Cromphaut, S. J. [1 ]
Vanhorebeek, I. [1 ]
Van den Berghe, G. [1 ]
机构
[1] Katholieke Univ Leuven, Dept Intens Care Med, Louvain, Belgium
关键词
critical illness; sepsis; hyperglycemia; hypoglycemia; tight glycemic control; insulin; mortality; morbidity;
D O I
10.2174/138161208784980563
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Hyperglycemia is a common feature of the critically ill in general and of patients with sepsis in particular. Even a moderate degree of hyperglycemia appears detrimental for the outcome of critically ill patients, since maintenance of normoglycemia (blood glucose levels 110 mg/dL) with intensive insulin therapy has shown to improve survival and reduce morbidity in prolonged critically ill patients in both surgical and medical intensive care units, as revealed by two large randomized controlled studies. Subsequently, questions have been raised regarding the efficacy and safety of this intervention, above all in the major subpopulation of intensive care patients presenting with sepsis, who are particularly susceptible to hypoglycemia as well. Adequately powered and executed randomized controlled trials addressing explicitly the impact of hyperglycemia, tight blood glucose control and the inherently increased risk of hypoglycemia on mortality and morbidity in patients with sepsis are presently lacking. However, the available literature suggests a causal link between hyperglycemia and adverse outcome in sepsis and a benefit of intensive insulin therapy in sepsis equal to the benefit found in critical illness without sepsis and critical illness in general. Though a high frequency of hypoglycemia may be noted during insulin treatment of patients with sepsis, the present observations define hypoglycemia as a marker of disease severity rather than a harmful treatment side-effect. Prevention of cellular glucose toxicity by strict glycemic control appears to play a predominant role, but other metabolic and nonmetabolic, anti-inflammatory effects of insulin seem to contribute to the clinical benefits realized.
引用
收藏
页码:1887 / 1899
页数:13
相关论文
共 163 条
[1]   Intravenous insulin decreases protein breakdown in infants on extracorporeal membrane oxygenation [J].
Agus, MSD ;
Javid, PJ ;
Ryan, DP ;
Jaksic, T .
JOURNAL OF PEDIATRIC SURGERY, 2004, 39 (06) :839-843
[2]  
Aljada A, 2004, AM J CLIN NUTR, V80, P51
[3]  
Allen Kate V, 2003, Endocr Pract, V9, P530
[4]   The proinflammatory cytokine macrophage migration inhibitory factor regulates glucose metabolism during systemic inflammation [J].
Atsumi, Toshiya ;
Cho, You-Ree ;
Leng, Lin ;
McDonald, Courtney ;
Yu, Tim ;
Danton, Cheryl ;
Hong, Eun-Gyoung ;
Mitchell, Robert A. ;
Metz, Christine ;
Niwa, Hirokatsu ;
Takeuchi, Jun ;
Onodera, Shin ;
Umino, Tomomi ;
Yoshioka, Narihito ;
Koike, Takao ;
Kim, Jason K. ;
Bucala, Richard .
JOURNAL OF IMMUNOLOGY, 2007, 179 (08) :5399-5406
[5]   Dynamics of protein nitration in cells and mitochondria [J].
Aulak, KS ;
Koeck, T ;
Crabb, JW ;
Stuehr, DJ .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004, 286 (01) :H30-H38
[6]   Effects of repeated hypoglycemia on cognitive function - A psychometrically validated reanalysis of the Diabetes Control and Complications Trial Data [J].
Austin, EJ ;
Deary, IJ .
DIABETES CARE, 1999, 22 (08) :1273-1277
[7]   Hyperglycemia and mortality in elderly patients with Staphylococcus aureus bacteremia [J].
Bader, Mazen S. .
SOUTHERN MEDICAL JOURNAL, 2007, 100 (03) :252-256
[8]   Hyperglycaemia and mortality of diabetic patients with candidaemia [J].
Bader, MS ;
Hinthorn, D ;
Lai, SM ;
Ellerbeck, EF .
DIABETIC MEDICINE, 2005, 22 (09) :1252-1257
[9]   PPAR dual agonists: Are they opening Pandora's box? [J].
Balakumar, Pitchal ;
Rose, Madhankumar ;
Ganti, Subrahmanya S. ;
Krishan, Pawan ;
Singh, Manjeet .
PHARMACOLOGICAL RESEARCH, 2007, 56 (02) :91-98
[10]   Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases [J].
Barnes, PJ ;
Larin, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) :1066-1071